Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.171,89
0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Centogene NV (CNTG) Centogene NV (CNTG) Notizie

Centogene NV

CNTG
0,4406
0,0066 (1,52%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/4/202422:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
19/3/202411:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
29/2/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202423:00GLOBECENTOGENE Collaborates on Research Published in Science..
28/2/202412:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202412:30GLOBECENTOGENE Announces Receipt of Nasdaq Notice of Delisting..
28/2/202412:30GLOBECENTOGENE Explores Strategic Alternatives
28/2/202412:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202412:30GLOBECENTOGENE and the Laboratory of Human Genetics of Infectious..
25/1/202412:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202412:30GLOBECENTOGENE Receives French Research Tax Credit Accreditation
24/1/202412:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202412:30GLOBECENTOGENE and The Michael J. Fox Foundation Announce..
18/1/202413:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/1/202412:30GLOBECENTOGENE Announces Preliminary Full Year 2023 Revenue
19/12/202313:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202312:30GLOBECENTOGENE Announces Voting Results of Extraordinary General..
18/12/202312:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202312:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202312:30GLOBECENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study,..
01/12/202312:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202312:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
28/11/202312:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202314:30GLOBECENTOGENE, University College London, and Global Team of..
03/11/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202313:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202312:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202312:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
06/10/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
07/9/202323:00GLOBECENTOGENE Reports First Half 2023 Financial Results
07/9/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202314:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
31/8/202322:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
31/8/202322:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202312:30GLOBECENTOGENE to Participate in Upcoming Conferences in August
14/7/202312:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/7/202312:30GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
12/7/202313:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202313:30GLOBECENTOGENE Biodatabank Reveals Unique Genetic Variants in..
02/7/202311:00PRNUSLifera and CENTOGENE, Enter Strategic Collaboration -..
30/6/202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202322:30GLOBECENTOGENE Announces Approval of All Resolutions Tabled at..
27/6/202313:30GLOBECENTOGENE and Lifera, a Biopharma Company Owned by the PIF,..
14/6/202322:30GLOBECENTOGENE Receives Nasdaq Notification Regarding Minimum..
17/5/202300:25GLOBECENTOGENE Reports Full Year 2022 Financial Results
Apertura: 0,438 Min: 0,43 Max: 0,4557
Chiusura: 0,434

La tua Cronologia

NASDAQ
CNTG
Centogene NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network